Advertisement
Canada markets open in 4 hours 48 minutes

  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • CAD/USD

    0.7247
    -0.0006 (-0.09%)
     

  • CRUDE OIL

    85.49
    +0.08 (+0.09%)
     

  • Bitcoin CAD

    87,443.24
    -4,085.22 (-4.46%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,386.50
    +3.50 (+0.15%)
     

  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     

  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,863.00
    -13.25 (-0.07%)
     

  • VOLATILITY

    19.20
    -0.03 (-0.16%)
     

  • FTSE

    7,845.96
    -119.57 (-1.50%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6826
    +0.0002 (+0.03%)
     
MARKETS LIVE BLOG:

STOCKS SLIP WITH MIDEAST TENSIONS, EARNINGS IN PLAY

Oil pares losses as traders anticipate Israel's response to Iranian attack

Initial Q3 Results Are Better-Than-Expected

Zacks Equity Research

As we await news reports from companies reporting Q3 results this morning, we see the October Empire State Index — which had been expected out this morning — was released in error yesterday, with a headline of 4.0. This is better than the 2.0 expected, and between recent highs (+24.3 in August 2018) and lows (-8.6 in June 2019).

Clearly, these results tend toward the more volatile, although interestingly, the estimates for this New York state production survey are almost always higher than the actual — though not for this month. This index looks to be bouncing off those recent lows; the end of the year will be key for this metric.

JPMorgan Chase (JPM), a Zacks Rank #3 (Hold) company, outperformed expectations on both top and bottom lines: $2.68 per share versus $2.44 expected. Revenues came in at $29.3 billion, above the $28.4 billion analysts were looking for. Fixed Income, working off a relatively weak year-over-year comp, was up 25% in Q3 2019, while Credit Loss Provisions rose 60% from the year-ago quarter.

Shares at this hour in the pre-market are up 1.9% on the news, and +7% year to date. JPMorgan has only come up short of earnings estimates once since Q1 2016. For more on JPM’s earnings, click here.

ADVERTISEMENT

Johnson & Johnson (JNJ), a Zacks Rank #4 (Sell)-rated stock ahead of its earnings report, beat estimates on both top and bottom lines this morning: $2.12 per share amounted to a 12-cent positive surprise, on sales of $20.73 billion which surpassed the $20.08 billion expected. Sales in its important Pharma space rose 5.1%.

J&J raised earnings guidance for full-year 2019 — up 9 cents on the bottom end of the range and +4 cents on the top, to $8.67 per share. Shares are up 1.66% at this moment of pre-market trading, coming up from its near-lows year to date. For more on JNJ’s earnings, click here.

These amount to just a sample of what we are about to see in the days and weeks ahead. Will Q3 bear out better than expected, or are we destined for an earnings recession? For a comprehensive view on the subject, check out this interview with Zacks Director of Research Sheraz Mian: Are We In an Earnings Recession?


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report
 
Johnson & Johnson (JNJ) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research